These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity. De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721 [No Abstract] [Full Text] [Related]
8. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris? Verros CD; Rallis E J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728 [No Abstract] [Full Text] [Related]
16. [Doubtful re-evaluation of Roaccutane]. Padoan SM Lakartidningen; 2003 Feb; 100(7):545. PubMed ID: 12640993 [No Abstract] [Full Text] [Related]
17. Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin. Fain K; Alexander GC Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):440-1. PubMed ID: 24706420 [No Abstract] [Full Text] [Related]
18. Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Fain K; Alexander GC Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1258-62. PubMed ID: 24115318 [No Abstract] [Full Text] [Related]
19. Low-dose schema of isotretinoin in acne vulgaris. Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017 [TBL] [Abstract][Full Text] [Related]
20. Comments on: are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Van Bennekom CM; Mitchell AA Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):439. PubMed ID: 24706419 [No Abstract] [Full Text] [Related] [Next] [New Search]